Fiche centre
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai — China
Essais liés6clinical trials
VilleShanghailocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06801236
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| LY4560736 | Alzheimer | Phase 1 | NCT07843459 | A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD) | NOT_YET_RECRUITING |
| SHR-2173 injection | Lupus | Phase 2 | NCT07299422 | A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus | RECRUITING |
| ACE-232 tablets | Cancer | Phase 1 | NCT06801236 | Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer | RECRUITING |
| LY4405094 | Alzheimer | Phase 1 | NCT07787169 | A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease | RECRUITING |
| LY4405094 | Alzheimer | Phase 1 | NCT07787182 | A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease | RECRUITING |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |